Suppr超能文献

肝脏 OATP 和 OCT 摄取转运体:其在药物相互作用和药物遗传学方面的作用。

Hepatic OATP and OCT uptake transporters: their role for drug-drug interactions and pharmacogenetic aspects.

机构信息

Department of Clinical Pharmacology and Clinical Toxicology, Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-University Erlangen-Nuremberg, Germany.

出版信息

Drug Metab Rev. 2010 Aug;42(3):380-401. doi: 10.3109/03602530903491683.

Abstract

Uptake transporters in the basolateral membrane of hepatocytes are important for the hepatobiliary elimination of drugs. Further, since drug-metabolizing enzymes are located intracellularly, uptake into hepatocytes is a prerequisite for their subsequent metabolism. Therefore, alteration of uptake transporter function (e.g., by concomitantly administered drugs or due to functional consequences of genetic variations, leading to reduced transport function) may result in a change in drug pharmacokinetics. In this review, we focus on the hepatocellularly expressed members of the OATP and OCT family, their impact on transport-mediated drug-drug interactions, and on the functional consequences of variations in genes encoding these transporters.

摘要

肝细胞基底外侧膜中的摄取转运体对于药物的肝胆消除非常重要。此外,由于药物代谢酶位于细胞内,因此摄取进入肝细胞是其随后代谢的前提。因此,摄取转运体功能的改变(例如,由于同时给予的药物或由于遗传变异的功能后果导致转运功能降低)可能导致药物药代动力学的变化。在本综述中,我们重点介绍了 OATP 和 OCT 家族中在肝细胞中表达的成员,它们对转运介导的药物相互作用的影响,以及编码这些转运体的基因变异的功能后果。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验